Bio-Techne Corporation [TECH] Stock sold by Insider Nusse Roeland for $0.72 million

0
31
NUE

In a filing, Bio-Techne Corporation revealed its Director Nusse Roeland unloaded Company’s shares for reported $0.72 million on Aug 30. In the deal valued at $80.32 per share,8,939 shares were sold. As a result of this transaction, Nusse Roeland now holds 51,872 shares worth roughly $ 3.69 million.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.

Sponsored

Then, Kummeth Charles R. sold 80,000 shares, generating $7,069,024 in total proceeds. Upon selling the shares at $88.36, the Chief Executive Officer now owns 1,258,766 shares.

Before that, Kummeth Charles R. sold 322 shares. Bio-Techne Corporation shares valued at $26,726 were divested by the Chief Executive Officer at a price of $83.00 per share. As a result of the transaction, Kummeth Charles R. now holds 1,112,817 shares, worth roughly $79.2 million.

William Blair initiated its Bio-Techne Corporation [TECH] rating to an Outperform in a research note published on Monday.

Price Performance Review of TECH

On Monday, Bio-Techne Corporation [NASDAQ:TECH] saw its stock fall -3.37% to $71.17. On the same session, the stock had its day’s lowest price of $71.01, but rose to a high of $73.37. Over the last five days, the stock has lost -0.64%. Bio-Techne Corporation shares have fallen nearly -14.13% since the year began. Nevertheless, the stocks have fallen -10.02% over the past one year. While a 52-week high of $90.63 was reached on 07/21/23, a 52-week low of $68.00 was recorded on 03/13/23. SMA at 50 days reached $80.65, while 200 days put it at $79.73. A total of 0.89 million shares were traded, compared to the trading of 0.96 million shares in the previous session.

Levels Of Support And Resistance For TECH Stock

The 24-hour chart illustrates a support level at 70.33, which if violated will result in even more drops to 69.49. On the upside, there is a resistance level at 72.69. A further resistance level may holdings at 74.21. The Relative Strength Index (RSI) on the 14-day chart is 31.44, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.13, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.68%. Stochastics %K at 20.74% indicates the stock is a holding.

How much short interest is there in Bio-Techne Corporation?

A steep rise in short interest was recorded in Bio-Techne Corporation stocks on Aug 30, 2023, growing by 0.17 million shares to a total of 3.1 million shares. Yahoo Finance data shows the prior-month short interest on Jul 30, 2023 was 2.93 million shares. There was a rise of 5.48%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 2.54% of the overall stock float, the days-to-cover ratio (short ratio) rose to 3.94.

Bio-Techne Corporation [TECH] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 17,705,714 shares, or roughly 11.19% of the outstanding TECH shares. In other words, the investor’s shares have fallen by -58,024 from its previous 13-F filing of 17763738.0. Additionally, BlackRock Fund Advisors increased 1.89% of its stake after which the total value it holdings stand at $783,000,165, while SSgA Funds Management, Inc. added 2.17% of its stake to hold $502.87 million in the firm. Over the last quarter, BAMCO, Inc. purchased 982 shares of Bio-Techne Corporation, while Select Equity Group LP bought -1,126,819 shares. At present, T. Rowe Price Associates, Inc. is holding 3,855,297 shares valued at $302.26 million. Neuberger Berman Investment Advis owned 3,777,760 shares of the company at the time of its most recent 13F filing, worth $296.18 million.

According to FactSet, Bio-Techne Corporation’s share price will average $102.00 in the next year, based on opinions of analysts polled by the firm. This is up nearly 35.78 percent from its previous closing price of $73.65. Analysts expect Bio-Techne Corporation stock to reach the higher price of $120.00, while the lowest price estimate is $86.00. However, 13 analysts have rated TECH stock as a Buy in their predictions for 2023.

LEAVE A REPLY

Please enter your comment!
Please enter your name here